Mucins and mucosal protection in the gastrointestinal tract

New prospects for mucins in the pathology of gastrointestinal disease

A. P. Corfield, N. Myerscough, R. Longman, P. Sylvester, S. Arul, M. Pignatelli

Research output: Contribution to journalArticle

251 Citations (Scopus)

Abstract

Recent advances in the detection of the growing family of MUC genes using nucleic acid probes and both VNTR and non-VNTR antibodies are making a significant impact on the ability to detect patterns of expression in gastrointestinal disease. This progress suggests that it may be possible to identify disease phenotypes more readily than with previous glycosylation based detection. The clinical impact of these developments will be in improved diagnosis and prognosis in disease screening and expansion of the current antimucin vaccine trials with MUC1 and sialyl-Tn to other mucin genes implicated in gastrointestinal disease. Sharing of carbohydrate antigens with non-mucin glycoconjugates remains a significant limitation in this respect. The secretory and membrane associated nature of the MUC gene products requires clear functional significance, and regulation of these genes is only starting to be investigated. Future development will be aimed at identification of MUC gene product glycosylation in diseases related to the protective functions at the mucosal surface, their role in cell and matrix adhesion, and metastasis.

Original languageEnglish
Pages (from-to)589-594
Number of pages6
JournalGut
Volume47
Issue number4
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Gastrointestinal Diseases
Mucins
Gastrointestinal Tract
Pathology
Genes
Glycosylation
Nucleic Acid Probes
Cell-Matrix Junctions
Glycoconjugates
Vaccines
Carbohydrates
Neoplasm Metastasis
Phenotype
Antigens
Membranes
Antibodies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mucins and mucosal protection in the gastrointestinal tract : New prospects for mucins in the pathology of gastrointestinal disease. / Corfield, A. P.; Myerscough, N.; Longman, R.; Sylvester, P.; Arul, S.; Pignatelli, M.

In: Gut, Vol. 47, No. 4, 2000, p. 589-594.

Research output: Contribution to journalArticle

Corfield, A. P. ; Myerscough, N. ; Longman, R. ; Sylvester, P. ; Arul, S. ; Pignatelli, M. / Mucins and mucosal protection in the gastrointestinal tract : New prospects for mucins in the pathology of gastrointestinal disease. In: Gut. 2000 ; Vol. 47, No. 4. pp. 589-594.
@article{99ed86390dcd445b9c241b1fbebe0ac9,
title = "Mucins and mucosal protection in the gastrointestinal tract: New prospects for mucins in the pathology of gastrointestinal disease",
abstract = "Recent advances in the detection of the growing family of MUC genes using nucleic acid probes and both VNTR and non-VNTR antibodies are making a significant impact on the ability to detect patterns of expression in gastrointestinal disease. This progress suggests that it may be possible to identify disease phenotypes more readily than with previous glycosylation based detection. The clinical impact of these developments will be in improved diagnosis and prognosis in disease screening and expansion of the current antimucin vaccine trials with MUC1 and sialyl-Tn to other mucin genes implicated in gastrointestinal disease. Sharing of carbohydrate antigens with non-mucin glycoconjugates remains a significant limitation in this respect. The secretory and membrane associated nature of the MUC gene products requires clear functional significance, and regulation of these genes is only starting to be investigated. Future development will be aimed at identification of MUC gene product glycosylation in diseases related to the protective functions at the mucosal surface, their role in cell and matrix adhesion, and metastasis.",
author = "Corfield, {A. P.} and N. Myerscough and R. Longman and P. Sylvester and S. Arul and M. Pignatelli",
year = "2000",
doi = "10.1136/gut.47.4.589",
language = "English",
volume = "47",
pages = "589--594",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Mucins and mucosal protection in the gastrointestinal tract

T2 - New prospects for mucins in the pathology of gastrointestinal disease

AU - Corfield, A. P.

AU - Myerscough, N.

AU - Longman, R.

AU - Sylvester, P.

AU - Arul, S.

AU - Pignatelli, M.

PY - 2000

Y1 - 2000

N2 - Recent advances in the detection of the growing family of MUC genes using nucleic acid probes and both VNTR and non-VNTR antibodies are making a significant impact on the ability to detect patterns of expression in gastrointestinal disease. This progress suggests that it may be possible to identify disease phenotypes more readily than with previous glycosylation based detection. The clinical impact of these developments will be in improved diagnosis and prognosis in disease screening and expansion of the current antimucin vaccine trials with MUC1 and sialyl-Tn to other mucin genes implicated in gastrointestinal disease. Sharing of carbohydrate antigens with non-mucin glycoconjugates remains a significant limitation in this respect. The secretory and membrane associated nature of the MUC gene products requires clear functional significance, and regulation of these genes is only starting to be investigated. Future development will be aimed at identification of MUC gene product glycosylation in diseases related to the protective functions at the mucosal surface, their role in cell and matrix adhesion, and metastasis.

AB - Recent advances in the detection of the growing family of MUC genes using nucleic acid probes and both VNTR and non-VNTR antibodies are making a significant impact on the ability to detect patterns of expression in gastrointestinal disease. This progress suggests that it may be possible to identify disease phenotypes more readily than with previous glycosylation based detection. The clinical impact of these developments will be in improved diagnosis and prognosis in disease screening and expansion of the current antimucin vaccine trials with MUC1 and sialyl-Tn to other mucin genes implicated in gastrointestinal disease. Sharing of carbohydrate antigens with non-mucin glycoconjugates remains a significant limitation in this respect. The secretory and membrane associated nature of the MUC gene products requires clear functional significance, and regulation of these genes is only starting to be investigated. Future development will be aimed at identification of MUC gene product glycosylation in diseases related to the protective functions at the mucosal surface, their role in cell and matrix adhesion, and metastasis.

UR - http://www.scopus.com/inward/record.url?scp=0033799905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033799905&partnerID=8YFLogxK

U2 - 10.1136/gut.47.4.589

DO - 10.1136/gut.47.4.589

M3 - Article

VL - 47

SP - 589

EP - 594

JO - Gut

JF - Gut

SN - 0017-5749

IS - 4

ER -